Showing results (61-70 of 351) with videos related to
Sort By:
Pageof 36
Clinical Pharmacology and Therapeutics|October 12, 2016
Comment on: "Cell therapy for heart disease: Trial sequential analyses of two cochrane reviews"G Castellini, E E Nielsen, C GluudHepatology (Baltimore, Md.)|March 1, 1988
Prognostic indicators in alcoholic cirrhotic menC Gluud, J H Henriksen, G NielsenAlimentary Pharmacology & Therapeutics|September 15, 2010
Meta-analysis: ribavirin plus interferon vs. interferon monotherapy for chronic hepatitic C - an updated Cochrane reviewJ Brok, L-L Gluud, C GluudThe Cochrane Database of Systematic Reviews|March 1, 2002
Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis CL L Kjaergard, K Krogsgaard, C GluudThe Cochrane Database of Systematic Reviews|July 20, 2007
WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis CL L Gluud, K Krogsgaard, C GluudUgeskrift for Laeger|March 6, 1989
[The effect of anabolic androgenic steroids on muscle strength, body weight and lean body mass in body-building men]M Søe, K L Jensen, C GluudBMJ (Clinical Research Ed.)|November 17, 2001
Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trialsL L Kjaergard, K Krogsgaard, C GluudAnnals of Internal Medicine|December 4, 2001
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analysesL L Kjaergard, J Villumsen, C GluudLiver|April 1, 1992
Liver pathology associated with the use of anabolic-androgenic steroidsK L Søe, M Søe, C GluudThe Cochrane Database of Systematic Reviews|July 22, 2005
Ribavirin plus interferon versus interferon for chronic hepatitis CJ Brok, L L Gluud, C GluudPageof 36